SAGILITY LIMITED (SAGILITY) Q2 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

Sagility Limited is a technology-enabled, pure-play healthcare solutions provider serving U.S.-based payers and providers, including five of the top ten U.S. health insurance companies. The Q2 print will speak to whether Adjusted EBITDA margin recovers within the guided 24-25% band after four straight quarters of decline, and how much of the 120 basis point Karnataka/Telangana minimum wage impact has been absorbed, with a favourable rupee the swing factor toward the upper end.

SAGILITY LIMITED Q2 Results Date and Time

The Board of Directors is scheduled to meet on October 22, 2026, to consider the unaudited Q2/H1 FY27 (quarter/half-year ended September 30, 2026) financial results with Limited Review, and to consider an interim dividend for FY 2026-27. The trading window remains closed from October 1 to October 24, 2026, until 48 hours after the results.

Sagility will host its Q2 FY27 earnings webinar on October 22, 2026, at 7:30 PM IST via Zoom, with pre-registration mandatory. Presenters are Mr. Ramesh Gopalan (MD & Group CEO) and Mr. Srinivas Rathnam Mattapalli (Group CFO).

What to expect from SAGILITY LIMITED's Q2 FY27 results

The Q2 FY27 print is a checkpoint for management's own promise of 'greater visibility into the full-year outlook by the end of Q2', with FY27 guidance reaffirmed at Q1 — low double-digit organic constant-currency revenue growth and a 24-25% Adjusted EBITDA margin. Margin is the central watch point: Adjusted EBITDA margin has declined four straight quarters (26.2% to 26.0% to 24.9% to 24.0%), and Q2 carries the full-quarter weight of the Karnataka/Telangana minimum-wage revisions — a 120 basis point FY27 impact on the roughly 65-70% of headcount in Bangalore and Hyderabad — plus about 50 basis points from annual salary increases. The offset is currency: the rupee's depreciation through July-September supports reported INR growth on a virtually all-USD-billed revenue base, and management has said that 'if the FX stays in the current ranges, it's more likely to track towards the upper end' of the 24-25% margin band. Demand signals remain supportive of the cost-takeout thesis — management stated it is 'not observing a general slowdown in spending from payers' and is engaged with 7 of the top 10 national insurers — while CareSeed, acquired on June 11, 2026 for USD 30.0 Mn in total contractual consideration, contributes its first full quarter. Seasonal open-enrolment revenues, which softened in Q1, are guided to return in Q3 and Q4 FY27 at close to 6% of revenues, similar to FY26.

Key Things To Watch

Guidance scorecard into the October 22, 2026 call: Tracking of management's stated FY27 commitments:

• Organic CC revenue growth — low double-digit for FY27 — Q1 FY27 organic CC at +14.9%
• Adjusted EBITDA margin — 24%-25% for FY27 — Q1 FY27 at 24.0%, with FX condition favouring the upper end
• Debt — repay all debt by end of FY27 — Rs. 149.50 Cr of bonds redeemed July 3, 2026; 4,175 bonds outstanding
• Seasonal (OE/AEP) revenue — ~6% of revenues for FY27 — expected to return in Q3 and Q4 FY27
• Dividend payout ratio — directional guidance pending since Q2 FY26

Margin trajectory and wage-impact absorption

• Q4 FY26 to Q1 FY27 margin bridge: ~40 bps from statutory minimum wage revisions, ~50 bps from annual salary increases, ~100 bps from operating-leverage normalisation as open-enrolment volumes seasonally softened
• Whether Q2 FY27 margin recovers within the 24-25% band and how much of the 120 bps Karnataka/Telangana wage impact has been absorbed
• Whether favourable FX lets management point to the upper end of the 24-25% guidance range

CareSeed integration and ACV momentum

• Whether quarterly steady-state ACV holds near the $30-35 Mn run-rate ($35.3 Mn in Q1 FY27) and any update on the $570-575 Mn sales pipeline
• The large onshore-to-offshore migration at a specific client, which management said is reducing that client cohort's revenue

Interim dividend and debt elimination path

• Board to consider an interim dividend for FY 2026-27 on October 22, 2026 — watch for movement toward the promised payout-ratio directional guidance
• Redemption pace toward 'all debt repaid by end-FY27' against 4,175 bonds outstanding after the July 3, 2026 redemption

Risks and headwinds to monitor

• Voluntary attrition: whether the easing to 28.6% in Q1 FY27 continues after the Q4 FY26 spike to 38.1%, and its linkage to wage revisions and the annual increment cycle
• ACA subsidy expiration: a 29% decline in new consumers and 3.4% decline in total enrollment in 2026 vs 2025, with management repeatedly stating Sagility's ACA exposure is very low
• AI-led deflation: the previously factored ~1.5% AI-led revenue deflation may remain relevant, as reported growth is net of all forms of cannibalization